IDEXX Depreciation And Amortization vs Non Current Assets Total Analysis

0J8P Stock

434.17 3.78 0.86%

IDEXX Laboratories financial indicator trend analysis is infinitely more than just investigating IDEXX Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IDEXX Laboratories is a good investment. Please check the relationship between IDEXX Laboratories Depreciation And Amortization and its Non Current Assets Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Depreciation And Amortization vs Non Current Assets Total

Depreciation And Amortization vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IDEXX Laboratories Depreciation And Amortization account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.

The correlation between IDEXX Laboratories' Depreciation And Amortization and Non Current Assets Total is 0.95. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of IDEXX Laboratories, assuming nothing else is changed. The correlation between historical values of IDEXX Laboratories' Depreciation And Amortization and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of IDEXX Laboratories are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Depreciation And Amortization i.e., IDEXX Laboratories' Depreciation And Amortization and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.Selling General Administrative is likely to drop to about 187 M in 2024. Tax Provision is likely to drop to about 109.4 M in 2024

	2021	2022	2023	2024 (projected)
Total Revenue	3.2B	3.4B	3.7B	3.8B
Depreciation And Amortization	104.6M	111.9M	114.9M	120.7M

Total Revenue Depreciation And Amortization

IDEXX Laboratories fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Non Current Liabilities Total	Intangible Assets	Short Long Term Debt Total	Short Term Debt	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		0.95	0.75	0.73	0.99	0.49	0.91	0.95	0.63	0.98	0.76	0.48	0.98	-0.32	0.97	0.47	-0.92	0.82	0.96	0.77	0.68	0.69	0.14	0.54	0.88	0.6
Other Current Liab	0.95		0.71	0.59	0.95	0.57	0.82	0.97	0.46	0.96	0.85	0.33	0.96	-0.41	0.9	0.46	-0.86	0.86	0.87	0.88	0.69	0.71	0.1	0.59	0.87	0.75
Total Current Liabilities	0.75	0.71		0.19	0.72	0.86	0.52	0.77	0.27	0.69	0.43	0.48	0.69	-0.28	0.76	0.78	-0.65	0.92	0.78	0.73	0.55	0.94	0.75	0.67	0.77	0.56
Total Stockholder Equity	0.73	0.59	0.19		0.71	-0.22	0.89	0.59	0.75	0.72	0.6	0.33	0.73	0.05	0.74	-0.01	-0.75	0.2	0.69	0.19	0.57	0.03	-0.37	0.14	0.51	0.09
Property Plant And Equipment Net	0.99	0.95	0.72	0.71		0.49	0.9	0.95	0.59	0.99	0.78	0.41	0.98	-0.37	0.96	0.41	-0.91	0.81	0.93	0.79	0.63	0.68	0.09	0.51	0.88	0.65
Net Debt	0.49	0.57	0.86	-0.22	0.49		0.17	0.61	-0.14	0.47	0.31	0.22	0.48	-0.54	0.48	0.65	-0.35	0.89	0.48	0.79	0.26	0.95	0.74	0.51	0.55	0.64
Retained Earnings	0.91	0.82	0.52	0.89	0.9	0.17		0.84	0.67	0.92	0.76	0.3	0.92	-0.19	0.93	0.27	-0.97	0.55	0.83	0.5	0.72	0.38	-0.08	0.33	0.7	0.42
Accounts Payable	0.95	0.97	0.77	0.59	0.95	0.61	0.84		0.4	0.97	0.82	0.3	0.97	-0.43	0.93	0.46	-0.89	0.86	0.87	0.83	0.71	0.73	0.18	0.53	0.85	0.69
Cash	0.63	0.46	0.27	0.75	0.59	-0.14	0.67	0.4		0.52	0.25	0.76	0.53	0.18	0.56	0.3	-0.55	0.27	0.73	0.23	0.32	0.19	-0.14	0.32	0.55	0.14
Non Current Assets Total	0.98	0.96	0.69	0.72	0.99	0.47	0.92	0.97	0.52		0.84	0.31	1.0	-0.37	0.96	0.39	-0.94	0.79	0.89	0.78	0.71	0.64	0.06	0.5	0.85	0.65
Non Currrent Assets Other	0.76	0.85	0.43	0.6	0.78	0.31	0.76	0.82	0.25	0.84		-0.03	0.84	-0.32	0.75	0.12	-0.77	0.58	0.6	0.64	0.67	0.39	-0.14	0.36	0.66	0.57
Cash And Short Term Investments	0.48	0.33	0.48	0.33	0.41	0.22	0.3	0.3	0.76	0.31	-0.03		0.33	0.08	0.39	0.5	-0.23	0.41	0.7	0.31	0.09	0.47	0.3	0.39	0.5	0.04
Net Receivables	0.98	0.96	0.69	0.73	0.98	0.48	0.92	0.97	0.53	1.0	0.84	0.33		-0.41	0.96	0.37	-0.93	0.8	0.9	0.78	0.68	0.65	0.06	0.47	0.84	0.63
Common Stock Shares Outstanding	-0.32	-0.41	-0.28	0.05	-0.37	-0.54	-0.19	-0.43	0.18	-0.37	-0.32	0.08	-0.41		-0.27	-0.05	0.3	-0.5	-0.22	-0.63	0.11	-0.48	-0.04	0.2	-0.11	-0.55
Inventory	0.97	0.9	0.76	0.74	0.96	0.48	0.93	0.93	0.56	0.96	0.75	0.39	0.96	-0.27		0.46	-0.93	0.77	0.92	0.68	0.75	0.66	0.2	0.5	0.82	0.52
Other Current Assets	0.47	0.46	0.78	-0.01	0.41	0.65	0.27	0.46	0.3	0.39	0.12	0.5	0.37	-0.05	0.46		-0.43	0.69	0.56	0.52	0.56	0.74	0.74	0.76	0.56	0.52
Other Stockholder Equity	-0.92	-0.86	-0.65	-0.75	-0.91	-0.35	-0.97	-0.89	-0.55	-0.94	-0.77	-0.23	-0.93	0.3	-0.93	-0.43		-0.68	-0.82	-0.62	-0.76	-0.53	-0.09	-0.42	-0.74	-0.58
Total Liab	0.82	0.86	0.92	0.2	0.81	0.89	0.55	0.86	0.27	0.79	0.58	0.41	0.8	-0.5	0.77	0.69	-0.68		0.8	0.94	0.5	0.97	0.52	0.65	0.83	0.78
Total Current Assets	0.96	0.87	0.78	0.69	0.93	0.48	0.83	0.87	0.73	0.89	0.6	0.7	0.9	-0.22	0.92	0.56	-0.82	0.8		0.71	0.6	0.72	0.25	0.56	0.86	0.48
Non Current Liabilities Total	0.77	0.88	0.73	0.19	0.79	0.79	0.5	0.83	0.23	0.78	0.64	0.31	0.78	-0.63	0.68	0.52	-0.62	0.94	0.71		0.39	0.86	0.26	0.55	0.77	0.87
Intangible Assets	0.68	0.69	0.55	0.57	0.63	0.26	0.72	0.71	0.32	0.71	0.67	0.09	0.68	0.11	0.75	0.56	-0.76	0.5	0.6	0.39		0.36	0.19	0.64	0.62	0.41
Short Long Term Debt Total	0.69	0.71	0.94	0.03	0.68	0.95	0.38	0.73	0.19	0.64	0.39	0.47	0.65	-0.48	0.66	0.74	-0.53	0.97	0.72	0.86	0.36		0.69	0.61	0.73	0.68
Short Term Debt	0.14	0.1	0.75	-0.37	0.09	0.74	-0.08	0.18	-0.14	0.06	-0.14	0.3	0.06	-0.04	0.2	0.74	-0.09	0.52	0.25	0.26	0.19	0.69		0.48	0.28	0.19
Common Stock	0.54	0.59	0.67	0.14	0.51	0.51	0.33	0.53	0.32	0.5	0.36	0.39	0.47	0.2	0.5	0.76	-0.42	0.65	0.56	0.55	0.64	0.61	0.48		0.8	0.61
Short Term Investments	0.88	0.87	0.77	0.51	0.88	0.55	0.7	0.85	0.55	0.85	0.66	0.5	0.84	-0.11	0.82	0.56	-0.74	0.83	0.86	0.77	0.62	0.73	0.28	0.8		0.68
Current Deferred Revenue	0.6	0.75	0.56	0.09	0.65	0.64	0.42	0.69	0.14	0.65	0.57	0.04	0.63	-0.55	0.52	0.52	-0.58	0.78	0.48	0.87	0.41	0.68	0.19	0.61	0.68

Click cells to compare fundamentals

IDEXX Laboratories Account Relationship Matchups

IDEXX Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	2.3B	2.4B	2.7B	3.3B	3.4B
Other Current Liab	276.5M	355.2M	396.4M	364.7M	372.4M	391.0M
Total Current Liabilities	725.3M	582.8M	763.6M	1.2B	951.5M	999.1M
Total Stockholder Equity	177.5M	632.1M	690.0M	608.7M	1.5B	1.6B
Property Plant And Equipment Net	533.8M	555.2M	587.7M	649.5M	817.7M	858.6M
Net Debt	897.3M	524.6M	779.2M	1.2B	613.4M	644.1M
Retained Earnings	1.6B	2.2B	2.9B	3.6B	4.4B	4.7B
Accounts Payable	72.2M	74.6M	116.1M	110.2M	110.6M	116.2M
Cash	90.3M	383.9M	144.5M	112.5M	453.9M	476.6M
Non Current Assets Total	1.2B	1.2B	1.5B	1.6B	1.8B	1.9B
Non Currrent Assets Other	299.0M	337.2M	397.4M	425.6M	333.0M	349.6M
Cash And Short Term Investments	90.3M	383.9M	144.5M	112.5M	453.9M	476.6M
Net Receivables	307.5M	374.7M	425.6M	490.9M	529.5M	556.0M
Common Stock Shares Outstanding	87.5M	86.7M	86.6M	84.6M	84.0M	94.9M
Liabilities And Stockholders Equity	1.8B	2.3B	2.4B	2.7B	3.3B	3.4B
Inventory	195.0M	209.9M	269.0M	367.8M	380.3M	399.3M
Other Current Assets	86.8M	94.2M	116.6M	130.2M	131.5M	75.1M
Other Stockholder Equity	(1.4B)	(1.5B)	(2.2B)	(2.9B)	(2.9B)	(2.8B)
Total Liab	1.7B	1.7B	1.7B	2.1B	1.8B	1.9B
Total Current Assets	679.6M	1.1B	955.7M	1.1B	1.5B	1.6B
Non Current Liabilities Total	929.3M	1.1B	983.6M	902.2M	823.8M	865.0M
Intangible Assets	58.5M	52.5M	99.0M	97.7M	84.5M	66.7M
Short Long Term Debt Total	987.7M	908.5M	923.7M	1.3B	1.1B	1.1B
Short Term Debt	304.0M	67.7M	168.4M	674.4M	344.8M	212.2M
Accumulated Other Comprehensive Income	(46.2M)	(53.6M)	(53.5M)	(77.8M)	(71.2M)	(67.6M)
Common Stock	10.6M	10.6M	10.7M	10.7M	10.8M	9.2M
Current Deferred Revenue	41.5M	42.6M	40.0M	37.9M	37.2M	25.0M
Good Will	239.7M	243.3M	359.3M	361.8M	366.0M	218.6M
Other Assets	240.2M	289.6M	325.2M	1.0	1.15	1.09
Other Liab	162.9M	143.5M	121.0M	106.6M	95.9M	115.4M
Net Tangible Assets	(120.7M)	336.2M	231.6M	149.3M	171.7M	180.2M
Long Term Debt	499.6M	599.5M	858.5M	775.2M	891.5M	711.1M
Deferred Long Term Liab	108.6M	116.1M	122.4M	119.9M	137.9M	115.7M
Property Plant Equipment	614.5M	646.3M	692.8M	768.1M	883.3M	648.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IDEXX Depreciation And Amortization vs Non Current Assets Total Analysis

Depreciation And Amortization vs Non Current Assets Total

Depreciation And Amortization vs Non Current Assets Total Correlation Analysis

Correlation Coefficient

Depreciation And Amortization

Non Current Assets Total

IDEXX Laboratories fundamental ratios Correlations

IDEXX Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

IDEXX Laboratories fundamental ratios Accounts

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 1.0	Non Current Assets Total
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Non Current Assets Total	+ 0.98	Total Assets
Net Receivables	+ 0.98	Total Assets
Net Receivables	+ 0.98	Property Plant And Equipment Net

Other Stockholder Equity	- 0.97	Retained Earnings
Other Stockholder Equity	- 0.94	Non Current Assets Total
Other Stockholder Equity	- 0.93	Inventory
Other Stockholder Equity	- 0.93	Net Receivables
Other Stockholder Equity	- 0.92	Total Assets
Other Stockholder Equity	- 0.91	Property Plant And Equipment Net